PD-1 Blockade With Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma
New England Journal of Medicine - United States
doi 10.1056/nejmoa1411087
Full Text
Open PDFAbstract
Available in full text
Categories
Date
January 22, 2015
Authors
Publisher
Massachusetts Medical Society